Hims Hers Health is trading 4.67% higher at $29.37 on October 9, 2026, rebounding from its October 8 close of $28.06; no clear company-specific reason for the gain was identified. - Recent coverage highlighted a newly filed securities class action and its lead-plaintiff deadline; neither report establishes a reason for the rise. - The company’s planned accounting-officer transition took effect October 9. Major indexes showed modest gains, with no clearly decisive broad-market catalyst in the supplied data.